Search
for

    GlossaryHair Regenerative Medicine

    field focused on restoring hair growth using advanced techniques

    Hair Regenerative Medicine is a field of medical research and treatment focused on restoring hair growth by using advanced techniques like stem cell therapy, platelet-rich plasma (PRP) injections, and tissue engineering. These methods aim to stimulate the body's natural ability to regenerate hair follicles, offering potential solutions for conditions like alopecia and hair thinning.

    Related Terms

    Learn

    5 / 65 results

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Update and new paper from Dr tsuji

      in Update  24 upvotes 6 years ago
      Hair follicle regenerative therapy is being developed, with clinical trials planned in Japan, potentially allowing for hair cloning and eliminating the need for treatments like finasteride. If successful, the treatment could be available in Japan by 2025, but widespread access and affordability may take longer.

      community Petition: Make PP405 available tomorrow instead of 2030

      in Satire  336 upvotes 7 months ago
      PP405, a promising hair loss treatment, is expected to be available by 2027, with faster trials due to its topical nature. Users are eager for its release, comparing it to existing treatments like minoxidil and finasteride, but remain cautious about its long-term effectiveness.

      community Did UCLA Just Cure Baldness? Check this Out!

      in Research/Science  972 upvotes 1 year ago
      UCLA's PP405 shows promise in reactivating dormant hair follicles for hair loss treatment but is still in clinical trials. Minoxidil and finasteride remain common treatments until PP405 becomes available.

      community Riken develops new method for culturing hair follicles

       38 upvotes 7 years ago
      A new stem cell method for culturing hair follicles is being developed as an alternative to Minoxidil, finasteride, and RU58841. There are concerns about its cost and accessibility despite plans for commercialization.